0001209191-17-035372.txt : 20170525
0001209191-17-035372.hdr.sgml : 20170525
20170525162716
ACCESSION NUMBER: 0001209191-17-035372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170523
FILED AS OF DATE: 20170525
DATE AS OF CHANGE: 20170525
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEWIS EARL R
CENTRAL INDEX KEY: 0001230427
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 17870330
MAIL ADDRESS:
STREET 1: C/O NXSTAGE MEDICAL INC. (NXTM)
STREET 2: 439 SOUTH UNION STREET, 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-23
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001230427
LEWIS EARL R
87 PINCKNEY STREET
BOSTON
MA
02114
1
0
0
0
Common Stock
2017-05-23
4
P
0
5000
2.39
A
428012
D
Common Stock
2017-05-24
4
P
0
5000
2.37
A
433012
D
This transaction was executed in multiple trades at prices ranging from $2.37 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 404,762 shares of common stock held by the Reporting Person.
Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 409,762 shares of common stock held by the Reporting Person.
This form has been signed under power of attorney.
/s/ Chad Porter, by power of attorney
2017-05-25